Renal Denervation is Still Alive

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Renal Denervation is Still Alive

By Piedmont Heart Institute FEATURING Prashant Kaul, David Kandzari

0 views

September 14, 2018

Piedmont Heart interventional cardiologists discuss the latest outlook for using renal denervation to treat hypertension ...
read more ↘ at the Napa Valley Cardiology Conference. Dr. David Kandzari, just back from EuroPCR 2018 where he presented results from the SPYRAL HTN trial, talked about what has changed since an earlier trial of Medtronic’s Symplicity Renal Denervation System failed to meet its primary endpoint, and the current, more positive implications for patient care.
↖ read less

Comments 0